2021, Vol. 5 Issue 1, Part APages: 43-48
The efficacy and safety of a Unani compound drug ‘Damavi’ in cases of anaemia: A preliminary study
RS Verma, S Parveen, S Rehman, R Singh, S Afza, J Akhtar, S Ahmad and AA Khan
Viewed: 506 - Downloaded: 231
Anaemia is an urgent public health burden in India. Available synthetic medicines have serious side effects, therefore, medicines of herbal origin have been extensively used in therapeutic management of anaemia for a long time. The present study aims to evaluate the efficacy and safety of Unani compound drug damavi in cases of anaemia (soo-ul-qiniya). The data presented in this work is a part of a multicentric, open level clinical study conducted on 102 anaemia cases at Regional Research Institute of Unani Medicine, Aligarh, during 2015-2018. The statistical analysis of data presented was done by using one-way analysis of variance (ANOVA) followed by Dennett’s’ test and, p value of ≤0.05 was considered significant. In symptomatic studies a significant reduction in pallor, weakness, fatigue and dyspnoea respectively has been observed, when compared with the values of 1st -day and different follow-up of treatments. In haematological studies a significant increase in the level of haemoglobin, red blood corpuscles (RBC), packed cell volume (PCV) were observed. In biochemical studies, no significant changes were observed in liver function test and kidney function test. Therefore, it was concluded that Unani compound drug damavi is haematinic and is also safe for both liver and kidney functions and can be used in the patients of anaemia safely.
How to cite this article:
RS Verma, S Parveen, S Rehman, R Singh, S Afza, J Akhtar, S Ahmad, AA Khan. The efficacy and safety of a Unani compound drug ‘Damavi’ in cases of anaemia: A preliminary study. Int J Unani Integ Med 2021;5(1):43-48.